Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Clovis Oncology to Present at the BofA Securities 2022 Healthcare Conference


Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its President and Chief Executive Officer, Patrick J. Mahaffy, will present at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022, at 10:00 a.m. Pacific time. The conference will be held at the Encore hotel in Las Vegas.

A live webcast of the presentation can be accessed through the investor relations section of the Company's website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Company's website for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the US, Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com for more information, including additional office locations in the US and Europe.


These press releases may also interest you

at 03:47
Kingdee International Software Group Co., Ltd. ("Kingdee International", "Kingdee" or the "Company", together with its subsidiaries collectively referred to as the "Group"; Stock Code: 268.HK) is pleased to announce the audited consolidated results...

at 03:28
Between 11 March 2024 and 15 March 2024 Concentric AB (LEI code 5493002G9GMTKIP3PW19) ("Concentric") has repurchased in total 21,812 own shares (ISIN: SE0003950864) as part of the repurchase program initiated by the Board. The repurchases form part...

at 03:20
Vicore Pharma Holding (STO:VICO)AlmeeTM is the first digital therapy to address anxiety and quality of life in patients living with pulmonary fibrosis (PF).AlmeeTM has shown effectiveness in reducing anxiety symptoms and improving health-related...

at 03:20
Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in blood-based cancer monitoring, has received a positive International Preliminary Report on Patentability (IPRP) covering the use of TKa as a prognostic and monitoring...

at 03:15
Cielo, the world's leading Talent Acquisition Partner, today debuts the first generative AI (GenAI) for talent acquisition: CLO.ai. Based on a new set of industry principles for responsible AI use, the intelligent tool allows talent leaders to...

at 03:14
As previously announced, Electrolux Group has reorganized into three regional business areas as of 1 January 2024. To enable comparisons with future financial reporting, restated historical figures for the combined business area Europe, Asia-Pacific,...



News published on and distributed by: